phenylpropanolamine has been researched along with Urinary Retention in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kuo, HC; Kuo, YC; Liao, CH | 1 |
Blauwet, MB; Chapple, CR; Huang, M; Kaplan, SA; Khullar, V; Mitcheson, D; Siddiqui, E | 1 |
Bavendam, T; Guan, Z; Jones, JS; Kaplan, SA; Roehrborn, CG; Wang, JT | 1 |
Chang, HC; Chiu, B; Chung, SD; Kuo, HC; Liao, CH | 1 |
Chapple, CR; Cummings, J; Dorrepaal, C; Drogendijk, T; Kaplan, SA; Klecka, J; Martin, N; Mitcheson, D | 1 |
Blaakaer, J; Høye, K; Mattiasson, A; Wein, AJ | 1 |
Araño, P; Bosch, JL; Chapple, CR; De Ridder, D; Kramer, AE; Ridder, AM | 1 |
Kaplan, SA; Te, AE; Walmsley, K | 1 |
6 trial(s) available for phenylpropanolamine and Urinary Retention
Article | Year |
---|---|
Predictors of successful first-line antimuscarinic monotherapy in men with enlarged prostate and predominant storage symptoms.
Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Endosonography; Follow-Up Studies; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Surveys and Questionnaires; Tolterodine Tartrate; Treatment Outcome; Urinary Retention | 2013 |
Mirabegron 50 mg once-daily for the treatment of symptoms of overactive bladder: an overview of efficacy and tolerability over 12 weeks and 1 year.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Hypertension; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Thiazoles; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Retention; Urinary Tract Infections; Urination; Xerostomia | 2014 |
The efficacy of additive tolterodine extended release for 1-year in older men with storage symptoms and clinical benign proastatic hyperplasia.
Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Humans; International Cooperation; Male; Muscarinic Antagonists; Phenylpropanolamine; Prostatic Hyperplasia; Quality of Life; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Retention | 2011 |
Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Aged; Benzhydryl Compounds; Constipation; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Headache; Humans; Hypertension; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Single-Blind Method; Thiazoles; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urinary Retention; Xerostomia | 2013 |
Simplified bladder training augments the effectiveness of tolterodine in patients with an overactive bladder.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Behavior Therapy; Benzhydryl Compounds; Combined Modality Therapy; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Single-Blind Method; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urinary Retention | 2003 |
Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo- and tolterodine-controlled phase 2 dose-finding study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Single-Blind Method; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urinary Retention; Urination | 2004 |
2 other study(ies) available for phenylpropanolamine and Urinary Retention
Article | Year |
---|---|
Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.
Topics: Adrenergic alpha-Antagonists; Adult; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Diuresis; Drug Therapy, Combination; Humans; Male; Middle Aged; Multicenter Studies as Topic; Muscarinic Agonists; Organ Size; Phenylpropanolamine; Prostate; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Retention | 2009 |
Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Humans; Incidence; Male; Middle Aged; Muscarinic Antagonists; Penile Erection; Phenylpropanolamine; Prospective Studies; Prostatic Hyperplasia; Time Factors; Tolterodine Tartrate; Treatment Outcome; Urinary Retention; Urination | 2005 |